• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PPD adds new central laboratory services

PPD adds new central laboratory services

February 11, 2013
CenterWatch Staff

Global CRO Pharmaceutical Product Development (PPD) has expanded its testing capabilities at its Brussels and Singapore labs, offering clients additional microbiology, peripheral blood mononuclear cell and molecular pathology services.

Like its facility in Highland Heights, Ky., PPD's labs in Brussels and Singapore now offer a full range of microbiology testing services for bacteriology, mycology, parasitology and microbioterrorism pathogens. All three labs can conduct extensive virology testing, including real-time polymerase chain reaction, viral load, genotyping and SNP analysis. The laboratories also have the capability to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms.

"Adding these services to our Brussels and Singapore labs expands our ability to provide clients in Europe and Asia Pacific an important component of laboratory testing for infectious diseases," said Elena Logan, senior vice president of central labs for PPD. "PPD is unique in that we offer fully integrated clinical trial management and central laboratory services, enabling us to provide increased efficiencies, greater study flexibility and added value to our clients."

PPD has extensive experience in conducting infectious diseases studies, having conducted nearly 240 studies in this area over the past five years. During that time, central labs has handled almost 50 infectious disease studies that included nearly 25,000 screened patients.

"These new capabilities are significant enhancements to the broad portfolio of scientific and clinical expertise that we bring to the development of infectious disease products on behalf of our clients," said Carol Olson, M.D., Ph.D., executive medical director and PPD's therapeutic area head for infectious diseases. "They also further strengthen our ability to manage samples and efficiently conduct clinical studies in emerging regions where a growing proportion of infectious disease studies are performed."

PPD offers a flexible approach to microbiology testing, performing disk diffusion and/or broth dilution assays to determine antibiotic minimum inhibitory concentrations and provide data to be used for establishing breakpoints. Since infectious disease treatments being tested are not yet on the market, a diagnostic microbiology laboratory in a hospital relying solely on an automated platform may not have the flexibility needed to perform the required antibiotic susceptibility testing.

In addition to the expansion of its microbiology services, PPD also has continued to strengthen its testing services by selectively adding to its menu of validated assays, which enables the company to support the pharmaceutical industry's growing need for partners with extensive in-house testing platforms. Over the course of the past year, the company validated 100 assays, increasing its total menu of available assays to 800.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing